What are the anatomy, epidemiology, and risk factors of carcinoma of the maxilla, particularly in older adults with a history of tobacco use, alcohol consumption, or exposure to certain chemicals and radiation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Carcinoma of the Maxilla: Anatomy, Epidemiology, and Risk Factors

Anatomical Considerations

Maxillary carcinoma represents a distinct subset of head and neck malignancies, with squamous cell carcinoma accounting for over 90% of cases, predominantly affecting the posterior region of the upper jaw (70% of cases). 1, 2

  • The maxilla is part of the upper aerodigestive tract, with tumors commonly arising from the alveolar ridge, hard palate, and maxillary sinus 1
  • Posterior maxillary tumors are more common than anterior lesions, likely due to greater mucosal surface area and proximity to the oropharynx 2
  • The rich lymphatic drainage of the maxilla results in cervical lymph node metastases in approximately 35% of cases, similar to other oral cavity sites 2
  • Direct extension to adjacent structures including the mandible, masticator muscles, and bone is common and significantly impacts prognosis 3

Epidemiology

Maxillary carcinoma constitutes only a small fraction of head and neck cancers, with squamous cell carcinoma of the head and neck having a crude incidence of 34.6 per 100,000 per year in the European Union. 1, 2

  • Head and neck cancer is the seventh most common cancer worldwide and ninth most common in the United States 1
  • The mortality rate for head and neck squamous cell carcinoma is 13.7 per 100,000 per year 1
  • Maxillary tumors present more commonly in older adults, with a median age in the mid-40s to 50s for most head and neck malignancies 3, 4
  • Males are affected more frequently than females, with a male-to-female ratio of approximately 2:1 4

Risk Factors

Tobacco use and alcohol consumption are responsible for 75-85% of head and neck squamous cell carcinomas, with a synergistic multiplicative effect when combined, making them the dominant modifiable risk factors. 3, 1, 5

Primary Risk Factors

  • Tobacco use: Smoking increases risk substantially, with odds ratios reaching 4.7 for heavy smokers (≥40 cigarettes/day for ≥20 years) 5, 6
  • Alcohol consumption: More than two drinks per day substantially increases risk of oral cavity cancers, with beer consumption showing particularly strong associations (OR 3.8 for ≥15 beers/week) 3, 6
  • Combined tobacco and alcohol use: The combination produces a multiplicative rather than additive effect, dramatically increasing risk beyond either factor alone 3, 5

Secondary Risk Factors

  • HPV infection: While HPV-positive oropharyngeal cancer (particularly tonsil and base of tongue) accounts for 30-35% of oropharyngeal malignancies globally, maxillary tumors are less commonly HPV-associated 3, 7, 1
  • Prior radiation exposure: Radiation-induced osteosarcoma of the maxilla can occur after radiotherapy for nasopharyngeal carcinoma, with an incidence of 0.084% among treated patients 8
  • Industrial chemical exposure: Certain occupational exposures increase risk, though this is more established for sinonasal than maxillary tumors 3
  • Poor oral hygiene and chronic inflammation: These contribute to carcinogenesis risk in the oral cavity 3, 7

Clinical Implications of Risk Factors

  • History taking must specifically document tobacco and alcohol use patterns, as these are standard assessment components 3, 7
  • Current smokers at the time of diagnosis face a fourfold increased risk of second primary aerodigestive tract cancers compared to nonsmokers 6
  • Risk reduction occurs 5 years after smoking cessation, emphasizing the importance of counseling on risk factor modification 7, 6
  • Patients with prolonged alcohol and tobacco use history should undergo panendoscopy to evaluate for synchronous tumors 3

Prognostic Risk Factors

Stage at diagnosis is the most predictive factor for survival, with locally advanced disease (stage III or IV) having less than half the survival rate of early-stage disease (stage I or II). 3

  • Tumor size, differentiation grade, and lymphatic invasion correlate significantly with cervical lymph node metastases (p < 0.01) 2
  • Cervical metastases occur even in T1 tumors, supporting elective neck dissection in clinically node-negative patients 2
  • Locoregional extent including muscle or bone invasion, presence of fixed lymph nodes, and capsular rupture significantly worsen prognosis 3
  • The 5-year specific mortality for maxillary malignancies can reach 31% depending on histologic subtype 4

References

Guideline

Head and Neck Cancer Epidemiology and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Squamous cell carcinoma of the maxilla: Analysis of clinicopathological predictors for disease recurrence and metastatic behavior.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ameloblastic carcinoma of the maxilla: case report and review of the literature.

Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007

Research

Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver.

Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism, 2006

Guideline

Granular Oropharyngeal Lesions: Differential Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.